All In Biotech

Drug Trial Radar · NCT03712345

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase II Efficacy and Safety Study of IFX-1 in Add-On to Standard of Care in Granulomatosis With Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

Last checked: Nov 19, 2026Latest source record: May 26, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

20

Actual

Start

Oct 15, 2018

Primary completion

Sep 10, 2020

Study completion May 3, 2021

Sponsor

Lead sponsor
InflaRx GmbHIndustry
Sponsor type
Industry
Collaborators
IQVIA Pty Ltd
First posted
Oct 19, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the safety and tolerability of two dose regimens of IFX-1 as add-on to standard of care (SOC) in subjects with GPA and MPA compared with placebo.

Conditions

  • Granulomatosis With Polyangiitis (GPA)
  • Microscopic Polyangiitis (MPA)

Interventions

  • IFX-1 low doseDrug

    Single IV infusions of IFX-1

  • IFX-1 high doseDrug

    Single IV infusions of IFX-1

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number and Percentage of Participants With at Least One TEAE Per Treatment Group.Time frame: Week 24

Locations

38 sites in 2 countries. Site status is shown where the registry gives one.

  • Mayo Clinic Scottsdale

    Scottsdale, Arizona

  • Loma Linda University Clinical Trial Center

    Loma Linda, California

  • Science Connections, LLC

    Doral, Florida

  • University of Miami

    Miami, Florida

  • Rush University Medical Center

    Chicago, Illinois

  • University of Kansas Medical Center Research Institute, Inc.

    Kansas City, Kansas

  • LSU Health Sciences Center Shreveport

    Shreveport, Louisiana

  • Johns Hopkins Bayview Medical Center

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • University Of MI Medcl Ctr-RHU

    Ann Arbor, Michigan

  • Henry Ford Hospital

    Detroit, Michigan

  • University of Minnesota

    Minneapolis, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • Washington University

    St Louis, Missouri

  • University of New Mexico

    Albuquerque, New Mexico

  • Northwell Health, LLC PRIME

    New Hyde Park, New York

  • Hospital for Special Surgery

    New York, New York

  • University of Rochester Medical Center - Strong Memorial Hospital

    Rochester, New York

  • UNC Kidney Center, UNC-CH Division of Nephrology and Hypertension

    Chapel Hill, North Carolina

  • Trinity Medical Group

    Minot, North Dakota

  • Ohio State University Clinical Trials Management Office

    Columbus, Ohio

  • Oregon Health & Science University

    Portland, Oregon

  • BRCR Medical Center, Inc.

    Camp Hill, Pennsylvania

  • Altoona Center for Clinical Research, P.C.

    Duncansville, Pennsylvania

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • Low Country Rheumatology, PA

    North Charleston, South Carolina

  • Adriana Pop Moody Clinic PA

    Corpus Christi, Texas

  • Texas Health Resources

    Dallas, Texas

  • Texas Research Institute

    Fort Worth, Texas

  • Pioneer Research Solutions, Inc.

    Houston, Texas

  • UVA University Physicians Charlottesville

    Charlottesville, Virginia

  • West Virginia University

    Morgantown, West Virginia

  • University of Alberta Hospital

    Edmonton, Alberta, Canada

  • St. Josephs Healthcare

    Hamilton, Ontaria, Canada

  • Mount Sinai Hospital

    Toronto, Ontario, Canada

  • CHUM Centre de Recherche

    Québec, Quebec, Canada

  • Centre de Recherche Musculo-Squelettique

    Trois-Rivières, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.